This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ajay Saxena: Innovator in Pharmaceutical Formulations
Introduction
Ajay Saxena is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the performance of amorphous solids and solubilized formulations. His work aims to achieve therapeutic plasma concentrations, which is crucial for effective medication delivery.
Latest Patents
Ajay Saxena holds a patent for "Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations." This invention relates to solid amorphous Compound (I) and solid amorphous dispersions comprising Compound (I) along with one or more polymers. Additionally, it includes solution formulations that comprise Compound (I) and one or more co-solvents and surfactants. The formulations developed by Saxena exhibit enhanced stability and bioavailability, making them valuable in the pharmaceutical industry.
Career Highlights
Ajay Saxena is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the field of drug formulation. His expertise in creating stable and bioavailable formulations has positioned him as a key player in pharmaceutical research and development.
Collaborations
Throughout his career, Ajay has collaborated with several professionals, including Robert J. Garmise and Jaquan Kalani Levons. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical technologies.
Conclusion
Ajay Saxena's contributions to the field of pharmaceutical formulations highlight his innovative spirit and dedication to improving drug delivery systems. His patent on enhanced amorphous solid formulations is a testament to his expertise and commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
